A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication

NCT01875003 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

348

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Lebrikizumab
DRUG: Placebo
DRUG: Standard of Care

Sponsor

Hoffmann-La Roche